Superworth

Agilent Technologies price to free cash flow A

Market value divided by free cash flow over the last twelve months, since 2010.

Today, Nov 3, 2026
39.1×
10-year median
30.5×
Against its 10-year history
85th
percentile: 0 is its lowest day, 100 its highest
10-year range
20.9× to 49.6×
Peer median
30.3×

Agilent Technologies' price to free cash flow is 39.1× as of Nov 3, 2026.

That is above its ten-year median of 30.5×, higher than on 85% of days in the last ten years.

Over that time it ranged from 20.9× in Dec 2016 to 49.6× in Dec 2020.

The median for 10 diagnostics and research stocks of a similar size is 30.3×.

Price to free cash flow over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far38.3×29.9×41.3×
202534.1×22.3×40.0×
202428.2×23.2×30.0×
202327.6×21.2×45.5×
202243.4×28.0×45.5×
202137.2×32.4×49.0×
202045.3×27.6×49.6×
201930.6×22.9×30.6×
201823.1×22.2×33.9×
201730.3×23.4×33.6×
201622.4×20.6×33.3×
201535.3×25.0×69.6×
201427.4×13.7×27.4×
201314.2×9.2×14.2×
20129.6×8.3×11.1×
20118.1×8.1×19.5×
201017.3×17.0×22.8×

Against its peers

Companies in Medical - Diagnostics & Research nearest Agilent Technologies' size, closest first, today.

CompanyPrice to free cash flow
AAgilent Technologies39.1×
IDXXIDEXX Laboratories41.5×
WATWaters117×
IQVIQVIA19.4×
ILMNIllumina38.4×
MTDMettler-Toledo International39.6×
LHLabcorp25.0×
DGXQuest Diagnostics20.0×
MEDPMedpace25.6×
RVTYRevvity30.3×
DHRDanahern/m
Peer median30.3×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Agilent Technologies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.